Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
Abstract Background Metastatic castration-resistant prostate cancer (mCRPC) remains a therapeutic challenge and evidence for late-line treatments in real-life is limited. The present study investigates the efficacy and safety of an oral metronomic chemo-hormonal regimen including cyclophosphamide, e...
Main Authors: | Mustafa Asowed, Nils O Elander, Linn Pettersson, Maria Ekholm, Dimitrios Papantoniou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10780-y |
Similar Items
-
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
by: Benjamin Carcamo, et al.
Published: (2022-05-01) -
Metronomic Chemotherapy in Prostate Cancer
by: Piotr J. Wysocki, et al.
Published: (2022-05-01) -
Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01) -
A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer
by: Ioannis A. Voutsadakis
Published: (2018-01-01) -
Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review
by: Shruti Parshad, et al.
Published: (2022-05-01)